Collection of protocols of Team Deleidi used in the publication: “”LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson’s disease””

Meet the Authors

• 

  Federico Bertoli, MD

  Key Personnel: Team Schapira, 

  German Center for Neurodegenerative Diseases

• 

  Michela Deleidi, MD, PhD

  Co-PI (Core Leadership): Team Schapira, 

  Institut Imagine